Document is current
Any future updates will be listed below
-
Authors
Moonla, Chatphatai https://orcid.org/0000-0001-6257-0867
Sosothikul, Darintr https://orcid.org/0000-0003-1097-3482
Pongtanakul, Bunchoo https://orcid.org/0000-0003-4204-0118
Suwanawiboon, Bundarika https://orcid.org/0000-0002-9525-9351
Traivaree, Chanchai https://orcid.org/0000-0001-5635-1238
Natesirinilkul, Rungrote https://orcid.org/0000-0002-9840-3443
Sirachainan, Nongnuch https://orcid.org/0000-0001-8039-5476
Angchaisuksiri, Pantep https://orcid.org/0000-0001-5607-3485
- License Information
-
More Information
Article History
Received: 6 March 2023
Accepted: 30 April 2023
First Online: 10 May 2023
Declarations
:
: Not applicable.
: Not applicable.
: All the authors participated in the advisory board on whose basis the publication was developed. Authors C.M. and D.S. received honorarium from Pfizer (Thailand) Ltd. to participate in the advisory board. C.M. additionally reported receiving grants from Pfizer (Thailand) Ltd., Novo Nordisk Pharma (Thailand) Ltd., and Rachadapiseksompotch Fund, Chulalongkorn University outside the submitted work. All other authors stated that they had no interests which might be perceived as posing a conflict or bias.
